Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
1.
J Pers Med ; 14(5)2024 Apr 29.
Article in English | MEDLINE | ID: mdl-38793062

ABSTRACT

The fetal splenic artery pulsatility index is a parameter that reflects fetal well-being and has been used as a predictor of adverse pregnancy outcomes. The aim of this study was to investigate the predictive value of the splenic artery pulsatility index in gestational diabetes mellitus class A1 cases for intensive care unit admission. In this prospective case-controlled study, only sixty single pregnancy cases diagnosed with gestational diabetes mellitus class A1 were evaluated. Fetal splenic artery Doppler parameters such as peak systolic velocity, pulsatility index, resistivity index, and end-diastolic velocity were measured in all cases. The rate of requirements for the neonatal intensive care unit was noted. In cases requiring fetal intensive care, the fetal splenic pulsatility index was found to be statistically significantly lower than in healthy cases without it (0.94 ± 0.29 vs. 1.70 ± 0.53, respectively, p < 0.001, Student's t-test). When the fetal splenic PI cutoff value was selected as 1.105 cm3, the sensitivity was calculated as 97.9% and the specificity as 58.3% for predicting the need for fetal intensive care (AUC 0.968, p < 0.001, 95% CI 0.929-0.998). The use of a low fetal splenic artery PI parameter is a significant and good indicator for predicting the need for fetal intensive care according to the binary logistic regression analysis result (p = 0.006). This study suggests that evaluation of fetal splenic artery Doppler in mothers with gestational diabetes mellitus may be used to predict neonates requiring a newborn intensive care unit. Therefore, it is recommended that obstetricians use this simple, rapid, and valuable evaluation of fetal splenic artery Doppler and alert the neonatologist that a newborn intensive care unit may be required.

2.
J Obstet Gynaecol India ; 72(6): 497-502, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36506895

ABSTRACT

Background: This study aimed to investigate the serum levels of mucoprotein 3 in hypertensive diseases of pregnancy. Methods: In total, 60 consecutive women with gestational hypertensive diseases (gestational hypertension (n = 20), severe preeclampsia (n = 20), HELLP syndrome (n = 20)) and 20 pregnant women without any gestational hypertensive diseases were included for this prospective controlled study. Serum MUC3 protein levels were measured with commercially available ELISA kits. Results: Serum MUC3 protein level was the lowest in normal pregnant women (0.1047 ± 0.0295 ng/ml); while the severity of the disease increases, it significantly increased in severe preeclampsia (0.2700 ± 0.0199 ng/mL) and HELLP syndrome group (0.3494 ± 0.0455 ng/mL), but less in the gestational hypertension (0.2172 ± 0.0354 ng/mL) group. Mean serum MUC3 protein level differences were found the least in gestational hypertension (0.1125 ± 0.0107, p < 0.001), the most in HELLP syndrome (-0.2546 ± 0.0107, p < 0.001) compared with the pregnant control group. Conclusion: The increase in serum MUC3 protein concentration in these women supported the argument that serum MUC3 protein may be used as a marker indicating the severity of the gestational hypertensive diseases.

3.
Pregnancy Hypertens ; 26: 116-120, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34741882

ABSTRACT

OBJECTIVE: The immunological factors have role in the development of preeclampsia. The thymus is one of the main organs of the fetal immune system. The aim of this prospective clinical study was to investigate the association between fetal thymus volume and preeclampsia by adding the 3-dimensional measurement of thymus volume to the routine fetal ultrasound scan at 11-14 week of gestation. STUDY DESIGN: Totally 72 pregnant women in their first trimester of pregnancy were included and 3-D fetal thymus volume was measured with sonographic VOCAL programme. All women gestational period was followed. The data of women with preeclampsia (n = 10, study group) and without preeclampsia (n = 62, control group) were compared. MAIN OUTCOME MEASURES: Fetal thymus volume, preeclampsia development. RESULTS: Fetal thymus volume, mean gestational age at birth and newborn birthweight were found to be statistically lower in cases with preeclampsia compared with those without any complications. When the fetal thymus volume measured by the VOCAL programme in the study group was used as a marker for preeclampsia development, the limit value was 0.0375 cm3; sensitivity was 87.1% and specificity was 50% (AUC 85.3%, P < .001, 95% CI 0.751-0.949). As a result of binary logistic regression analysis; the low fetal thymus volume measured at 11-14 gestational weeks can be used as a predictive factor for preeclampsia (P < .001). CONCLUSIONS: According to the results of this study; the development of preeclampsia may be predicted by measuring 3-D fetal thymus volume at the first trimester.


Subject(s)
Pre-Eclampsia/diagnosis , Thymus Gland/embryology , Adult , Biomarkers/analysis , Case-Control Studies , Female , Humans , Imaging, Three-Dimensional/methods , Pregnancy , Pregnancy Trimester, First , Prospective Studies , Sensitivity and Specificity , Thymus Gland/diagnostic imaging , Ultrasonography, Prenatal/methods
4.
Prz Menopauzalny ; 20(2): 76-80, 2021 Jun.
Article in English | MEDLINE | ID: mdl-34321985

ABSTRACT

INTRODUCTION: To assess the effect of hormone therapy (HT) on serum ischemia modified albumin (IMA) levels in healthy menopausal women. MATERIAL AND METHODS: Thirty surgical menopausal women who were admitted to our menopausal polyclinic during a 1-year period and diagnosed with menopause and planned to have HT for menopausal symptoms were enrolled in this prospective study. The serum IMA levels were recorded before and after (3 months, 6 months, 12 months later) hormone treatment (2 mg estradiol hemihydrate). RESULTS: The mean age of women was 47.60 ± 2.34 years. The mean serum IMA levels were 0.610 ± 0.096 absorbance units (ABSU) at the beginning and 0.484 ± 0.080 ABSU after 3 months of hormone therapy. Following 6 months of hormone therapy, serum IMA level was 0.546 ± 0.075, and reached 0.580 ± 0.089 ABSU following 12 months of therapy. CONCLUSIONS: These findings suggest that HT may not block the menopause induced ischemia process. Although HT had a positive effect on serum IMA levels following 3 months' use, serum IMA levels returned to baseline levels after 12 months' use. Based on this study's findings, long-term use of HT may not have a positive effect on cardiovascular disease protection.

5.
J Obstet Gynaecol ; 39(8): 1160-1163, 2019 Nov.
Article in English | MEDLINE | ID: mdl-31335232

ABSTRACT

The aim of this study was to determine the serum biotin levels in patients with hyperemesis gravidarum (HG). Ninety pregnant women with HG (mild (n = 30), moderate (n = 30) and severe (n = 30)), and 80 pregnant women without HG were included for this study. In both groups, serum biotin levels were measured. There were no statistically significant differences in demographic and clinical characteristics between the HG groups and the control group except for PUQE scores. Serum biotin levels in all hyperemesis gravidarum groups were statistically significantly lower than control group. Negative statistically significant correlation between hyperemesis gravidarum severity and serum biotin levels was noted. This is the first study that shows low serum biotin levels in women with hyperemesis gravidarum. Impact statement What is already known on this subject? Almost 80% of pregnant women have nausea and vomiting. If nausea and vomiting became severe and the symptoms combined with weight loss and ketonuria; the diagnosis should be hyperemesis gravidarum (HG). The etiopathogenetic factors of this unwanted condition have not been exactly known. Biotin is an essential water-soluble vitamin. Biotin catabolism increases in pregnancy. Marginal biotin deficiency occurs in approximately 50% of the gestations despite the "normal" biotin intake on the diet. What do the results of this study add? Current study results elucidated that serum biotin levels were lower in HG cases compared to non HG cases. This study is the first study that reports the association between low serum level of biotin and HG. What are the implications of these findings for clinical practice and/or further research? Further research is needed to show the importance of biotin supplementation in women with hyperemesis gravidarum.


Subject(s)
Biotin/blood , Biotinidase Deficiency/epidemiology , Hyperemesis Gravidarum/blood , Adult , Biotinidase Deficiency/blood , Female , Gestational Age , Humans , Pregnancy , Pregnancy Complications/blood , Risk Factors , Severity of Illness Index
6.
Shanghai Arch Psychiatry ; 28(2): 86-94, 2016 Apr 25.
Article in English | MEDLINE | ID: mdl-27605864

ABSTRACT

BACKGROUND: Infertility is a major life crisis which can lead to the development of psychiatric symptoms and negative effects on the quality of life of affected couples, but the magnitude of the effects may vary depending on cultural expectations. AIM: We compare the level of psychiatric symptoms, disability, and quality of life in fertile and infertile women in urban Turkey. METHODS: This cross-sectional study enrolled 100 married women being treated for infertility at the outpatient department of the Obstetrics and Gynecology Department of the Rize Education and Research Hospital and a control group of 100 fertile married women. All study participants were evaluated with a socio-demographic data screening form, the Hospital Anxiety and Depression Scale (HADS), the Brief Disability Questionnaire (BDQ), and the Short Form Health Survey (SF-36). RESULTS: The mean anxiety subscale score and depression subscale score of HADS were slightly higher in the infertile group than in controls, but the differences were not statistically significant. The proportion of subjects with clinically significant anxiety (i.e., anxiety subscale score of HADS ≥11) was significantly higher in infertile women than in fertile women (31% v. 17%, χ (2)=5.37, p=0.020), but the proportion with clinically significant depressive symptoms (i.e., depression subscale score of HADS >8) was not significantly different (43% v. 33%, χ (2)=2.12, p=0.145). Self-reported disability over the prior month was significantly worse in the infertile group than in the controls, and 4 of the 8 subscales of the SF-36 - general health, vitality, social functioning, and mental health - were significantly worse in the infertile group. Compared to infertile women who were currently working, infertile women who were not currently working reported less severe depression and anxiety and better general health, vitality, and mental health. CONCLUSIONS: Married women from urban Turkey seeking treatment for infertility do not have significantly more severe depressive symptoms than fertile married controls, but they do report greater physical and psychological disability and a poorer quality of life. The negative effects of infertility were more severe in infertile women who were employed than in those who were not employed. Larger follow-up studies are needed to assess the reasons for the differences between these results and those reported in western countries which usually report a higher prevalence of depression and anxiety in infertile patients.

7.
J Matern Fetal Neonatal Med ; 29(4): 629-32, 2016.
Article in English | MEDLINE | ID: mdl-25708489

ABSTRACT

OBJECTIVE: The aim of this study was to evaluate maternal neutrophil gelatinase-asssociated lipocalin (NGAL) levels and fetal renal artery (fRA) Doppler flow indices in pregnant women fasting in Ramadan in respect of dehydration in long hot summer days as a marker of hypoperfusion and early renal injury. METHODS: A cross-sectional observational study was carried out at a University Hospital. Fasting pregnant women and non-fasting age, gravidity and gestational age-matched women were evaluated for hematologic, blood biochemistry and urine parameters in the first and fourth weeks of the Ramadan. Umbilical artery and fRA Doppler flows were studied in each evaluation. RESULTS: Blood urea nitrogen, potassium and hematocrit levels, blood and urine NGAL levels were significantly higher, and fRA Doppler indices increased in fasting women (p < 0.05) during the second visit in the last week of the Ramadan, while non-fasting women had no significant alterations in each evaluation (p > 0.05). CONCLUSIONS: Adequate maternal vascular volume is essential for the maintenance of healthy pregnancy. Fasting during the long and hot summer days leads to fluid deprivation and dehydration which was found to be related to subclinical maternal renal dysfunction and increased fRA Doppler indices.


Subject(s)
Acute-Phase Proteins/urine , Dehydration/physiopathology , Fasting/physiology , Lipocalins/blood , Lipocalins/urine , Pregnancy Complications/physiopathology , Proto-Oncogene Proteins/blood , Proto-Oncogene Proteins/urine , Renal Artery/diagnostic imaging , Adult , Blood Flow Velocity/physiology , Blood Urea Nitrogen , Cross-Sectional Studies , Fasting/adverse effects , Female , Hematocrit , Hot Temperature , Humans , Islam , Lipocalin-2 , Matched-Pair Analysis , Potassium/blood , Pregnancy , Turkey , Ultrasonography, Doppler , Ultrasonography, Prenatal , Umbilical Arteries/diagnostic imaging
8.
Gynecol Obstet Invest ; 80(2): 124-7, 2015.
Article in English | MEDLINE | ID: mdl-25998166

ABSTRACT

BACKGROUND: Urinary tract infections are among the most common bacterial infections of humans. Urine culture is the gold standard for asymptomatic bacteriuria and pyuria is not always present in bacteriuria, nor is it specific for bacteriuria. OBJECTIVE: The aim of the present study was to determine neutrophil activation and the contributions of this activation in the differentiation of infection and contamination. METHODS: The serum and urine myeloperoxidase (MPO) levels of 50 pregnant females with symptoms suggesting UTI and 25 healthy non-pregnant control subjects were measured using the enzyme-linked immunosorbent assay (ELISA) method and the obtained values were compared with the results of urine microscopy and urine culture. RESULTS: The leukocyte count in urine was significantly higher in group 1 (infection) and group 2 (contamination) when compared with the control group (group 1 mean: 18.2; group 2 mean: 14.2; control mean: 4.8; ANOVA test, p ≤ 0.00). According to the obtained ELISA values, a statistical difference in the levels of urine MPO between the patient and control groups was seen (p ≤ 0.00). There was no statistical difference among the groups for serum MPO levels (p ≥ 0.451). CONCLUSION: The study findings suggest that standardized measurement techniques such as dipstick screening assay for urine MPO level may be useful in differentiating infection and contamination, especially in pregnant patients.


Subject(s)
Neutrophil Activation/immunology , Pregnancy Complications, Infectious/urine , Urinary Tract Infections/urine , Urine/microbiology , Adult , Female , Humans , Leukocyte Count , Pregnancy , Pregnancy Complications, Infectious/blood , Urinalysis , Urinary Tract Infections/blood
9.
J Pediatr Adolesc Gynecol ; 28(1): 63-65, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25555303

ABSTRACT

STUDY OBJECTIVE: To determine the SCUBE1 levels in adolescents with primary dysmenorrhea. DESIGN: A prospective cross-sectional study. SETTING: A university hospital outpatient clinic, Rize, Turkey. PARTICIPANTS: A total of 40 adolescent girls, 15 on menses and 25 not on menses. INTERVENTIONS AND MAIN OUTCOME MEASURES: Demographic features and menstrual history of the participants were assessed and blood samples were obtained for detecting the platelet volume, platelet counts, and SCUBE1 levels of the participants. RESULTS: No difference was detected between the 2 groups in mean platelet volume, platelet count, and SCUBE1 levels. CONCLUSION: Future trials are required to investigate the relation between SCUBE1 levels and primary dysmenorrhea.


Subject(s)
Dysmenorrhea/blood , Hypoxia/blood , Membrane Proteins/blood , Adolescent , Biomarkers/blood , Calcium-Binding Proteins , Cross-Sectional Studies , Dysmenorrhea/etiology , Female , Humans , Hypoxia/complications , Platelet Count , Prospective Studies , Turkey
10.
Gynecol Obstet Invest ; 79(4): 269-75, 2015.
Article in English | MEDLINE | ID: mdl-25591981

ABSTRACT

AIM: The aim of this study is to evaluate the diagnostic value of serum oxidative stress marker levels (ischemia-modified albumin, IMA; malondialdehyde, MDA) and total oxidant status (TOS), total antioxidant status (TAS) and oxidative stress index (OSI) levels that occur in ovarian torsion and to determine the threshold value of these markers in the diagnosis of ovarian torsion. METHODS: In this prospective case-control study, 34 women (the study group) with acute pelvic pain (20 with and 14 without ovarian torsion) and 40 control subjects were included. The diagnosis of ovarian torsion was confirmed with laparoscopy in all cases. Preoperative serum samples were collected in the study group. Serum oxidative stress marker levels (IMA and MDA) and TOS, TAS and OSI levels were measured. RESULTS: Serum MDA, TOS and IMA concentrations were significantly higher in women with ovarian torsion than in the healthy control group. However, serum TAS, TOS and OSI concentrations were significantly higher in women without ovarian torsion than within the healthy control group. Only IMA significantly distinguished patients with or without ovarian torsion. The best IMA value, according to the receiver operating characteristic curve, was 0.7045 absorbance units, with 90.00% sensitivity and 92.31% specificity. The patients in the ovarian torsion group had significantly lower serum TAS and OSI levels compared with patients without ovarian torsion. CONCLUSION: The elevated serum IMA levels with high sensitivity-specificity values observed in women with ovarian torsion seem to have a potential role as a serum marker in the preoperative diagnosis of ovarian torsion in emergency settings.


Subject(s)
Hematologic Tests/standards , Ovarian Diseases/diagnosis , Oxidative Stress/physiology , Torsion, Mechanical , Acute Pain/etiology , Adult , Biomarkers/blood , Case-Control Studies , Female , Humans , Laparoscopy , Middle Aged , Ovarian Diseases/blood , Ovarian Diseases/complications , Ovarian Diseases/surgery , Pelvic Pain/etiology , Sensitivity and Specificity , Serum Albumin , Serum Albumin, Human
11.
Article in English | MEDLINE | ID: mdl-25462211

ABSTRACT

OBJECTIVE: Resveratrol, a phytoalexin polyphenol, has anti-angiogenic, antioxidant, anti-inflammatory properties. We aimed to compare the anti-inflammatory and anti-angiogenic effects of resveratrol and leuprolide acetate (LA) in an experimental endometriosis model. STUDY DESIGN: A prospective experimental study was conducted in a University Surgical Research Center. Thirty-three non-pregnant female Sprague-Dawley rats, in which experimental model of endometriosis were surgically induced were randomly divided into four groups. Group 1 was administered 30 mg/kg resveratrol i.m. for 14 days, group 2 was given 1mg/kg s.c. single dose LA, group 3 was administered both resveratrol and LA, and group 4 had no medication. After two weeks medication rats were sacrificed and size, histopathology and immunreactivity to matrix metalloproteinase (mmp)2, mmp9, vascular endothelial growth factor (VEGF) of the endometriotic implants were evaluated. Plasma and peritoneal fluid levels of interleukin (IL)-6, IL-8, and tumor necrosis factor-α (TNF-α) were analyzed. RESULTS: The endometriotic implant volumes, histopathological grade and immunreactivity to mmp2, mmp9 and VEGF were significantly reduced (p<0.001), and plasma and peritoneal fluid levels of IL-6, IL-8 and TNF-α were significantly decreased in group 1 and group 2 in comparison to group 3 and group 4 (p < 0.001). CONCLUSION: Resveratrol alone is a potential agent for the treatment of endometriosis and may be an alternative to LA. In contrast, the combination of LA and resveratrol decreased the anti-inflammatory and anti-angiogenic effects of each agent. Since resveratrol is widely used as an alternative therapy for a variety of conditions, it can undermine the effectiveness of LA. Therefore, caution should be exercised when used in combination with other agents.


Subject(s)
Angiogenesis Inhibitors/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Endometriosis/drug therapy , Endometrium/drug effects , Leuprolide/therapeutic use , Stilbenes/therapeutic use , Angiogenesis Inhibitors/pharmacology , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Disease Models, Animal , Endometriosis/metabolism , Endometriosis/pathology , Endometrium/metabolism , Endometrium/pathology , Female , Leuprolide/pharmacology , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase 9/metabolism , Rats , Rats, Sprague-Dawley , Resveratrol , Stilbenes/pharmacology , Treatment Outcome , Vascular Endothelial Growth Factor A/metabolism
12.
Arch Gynecol Obstet ; 289(6): 1171-5, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24464347

ABSTRACT

PURPOSE: To present the outcomes of four cases of cesarean scar pregnancy treated with suction curettage. METHODS: Four patients were ultrasonographically diagnosed with cesarean scar pregnancies treated with suction curettage in a tertiary care center. RESULTS: Serum ß-human chorionic gonadotropin levels ranged between 1,681 and 15,573 mU/mL, gestational sac diameter measured from 10 to 24 mm and scar thickness was between 4.7 and 6.8 mm. All patients underwent suction curettage under general anesthesia with transabdominal ultrasonography guidance. No complications were observed during or after operation. CONCLUSION: Suction curettage is a viable alternative for conservative treatment in selected cases of patients who are diagnosed with CSP early in gestation and who have a myometrial thickness of more than 4.5 mm.


Subject(s)
Cesarean Section/adverse effects , Cicatrix/complications , Pregnancy, Ectopic/surgery , Vacuum Curettage , Adult , Anesthesia, General , Blood Loss, Surgical , Chorionic Gonadotropin, beta Subunit, Human/blood , Early Diagnosis , Female , Humans , Pregnancy , Pregnancy, Ectopic/diagnostic imaging , Ultrasonography, Interventional
13.
Case Rep Obstet Gynecol ; 2014: 481380, 2014.
Article in English | MEDLINE | ID: mdl-25614844

ABSTRACT

Endometrial carcinoma is rarely seen during reproductive ages and commonly related to infertility, polycystic ovarian syndrome (PCOS), and obesity. Pregnancy associated endometrial carcinoma is even rarer and this is the second case reported in the literature concerning tubal pregnancy associated endometrial carcinoma. We present a case of a 36-year-old woman with a history of PCOS, infertility, and several attempts of ovulation induction and in vitro fertilization, who was diagnosed with tubal pregnancy and a well differentiated endometrial carcinoma. We also review the literature about pregnancy associated endometrial carcinoma in the first trimester.

14.
Turk J Obstet Gynecol ; 11(3): 153-158, 2014 Sep.
Article in English | MEDLINE | ID: mdl-28913009

ABSTRACT

OBJECTIVE: The aim of this study was detection of Female Sexual Function Index (FSFI) scores of married women living in North Eastern Black Sea region of Turkey and comparison with demographic data. MATERIALS AND METHODS: A cross-sectional, descriptive study conducted at a University Hospital, gynecology and obstetrics outpatient clinic. Married women between 18-50 years of age, without any complaint enrolled in the study and participants were asked to fill out the form of FSFI. Age, gravidity and number of living children, duration of marriage, education and income levels, employment status, and contraceptive methods has been questioned. Sexual desire, arousal, lubrication, orgasm, satisfaction, pain subscales, and total score of FSFI were determined and compared with demographic data. RESULTS: Lower FSFI levels were detected from 70.9% of the respondents. Age, duration of marriage and number of children were adversely affected the FSFI scores. Intermediate education level and usage of a contraceptive method were related with higher FSFI scores. Pain scores were high in all participants independently from other parameters. CONCLUSIONS: For identification of women's sexual dysfunction, increasing the knowledge level and awareness about sexuality are required.

15.
Asian Pac J Cancer Prev ; 14(10): 6121-5, 2013.
Article in English | MEDLINE | ID: mdl-24289636

ABSTRACT

BACKGROUND: Endometrial cancers are the most common gynecologic cancers. Endometrial sampling is a preferred procedure for diagnosis of the endometrial pathology. It is performed routinely in many clinics prior to surgery in order to exclude an endometrial malignancy. We aimed to investigate the accuracy of endometrial sampling in the diagnosis of endometrial pathologies and which findings need intra-operative frozen sections. MATERIALS AND METHODS: Three hundred nine women applying to a university hospital and undergoing endometrial sampling and hysterectomy between 2010 and 2012 were included to this retrospective study. Data were retrieved from patient files and pathology archives. RESULTS: There was 17 patients with malignancy but endometrial sampling could detect this in only 10 of them. The endometrial sampling sensitivity and specificity of detecting cancer were 58.8% and 100%, with negative and positive predictive values of 97.6%, and 100%, respectively. In 7 patients, the endometrial sampling failed to detect malignancy; 4 of these patients had a preoperative diagnosis of complex atypical endometrial hyperplasia and 2 patients had a post-menopausal endometrial polyps and 1 with simple endometrial hyperplasia. CONCLUSIONS: There is an increased risk of malignancy in post-menopausal women especially with endometrial polyps and complex atypia hyperplasia. Endometrial sampling is a good choice for the diagnosis of endometrial pathologies. However, the diagnosis should be confirmed by frozen section in patients with post-menopausal endometrial polyps and complex atypia hyperplasia.


Subject(s)
Endometrial Hyperplasia/pathology , Endometrial Neoplasms/pathology , Frozen Sections , Hysterectomy , Monitoring, Intraoperative , Adult , Aged , Aged, 80 and over , Endometrial Hyperplasia/surgery , Endometrial Neoplasms/surgery , Female , Follow-Up Studies , Humans , Male , Middle Aged , Prognosis , Retrospective Studies
16.
Gynecol Endocrinol ; 29(8): 749-53, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23741965

ABSTRACT

The aim of this study to evaluate the effect of cabergoline on follicular microenvironment by measuring follicular fluid (FF) insulin like growth hormone -I (IGF-I), antimullerian hormone (AMH), inhibin B and hepatocyte growth factor (HGF) levels in women with PCOS and high risk of ovarian hyperstimulation syndrome (OHSS). In this prospective cohort study, 41 women with PCOS undergoing controlled ovarian hyperstimulation for assisted reproduction and having the high risk factors for OHSS are included. The women in the study group (n = 15) received cabergoline for OHSS prevention while the women in the control did not received any medications for OHSS prevention. FF samples were collected during oocyte pick-up procedure for all women were determined using commercially available ELISA kits. Concentrations of FF IGF-I, AMH, inhibin B and HGF were assessed. In the study group FF AMH (2.96 ± 1.27 versus 1.91 ± 0.64 ng/mL), Inhibin B (1339.47 ± 198.56 versus 1200.09 ± 133.64 pg/mL), HGF (5623.21 ± 2411.09 versus 3787.42 ± 2269.89 pg/mL) and IGF-I (298.60 ± 37.80 versus 219.90 ± 71.40 pg/mL) concentrations were significantly decreased compared with control group. Cabergolin prevents OHSS in high risk patients by disrupting FF hormone microenvironment.


Subject(s)
Cellular Microenvironment/drug effects , Ergolines/administration & dosage , Follicular Fluid/drug effects , Ovarian Follicle/drug effects , Ovarian Hyperstimulation Syndrome/prevention & control , Adult , Anti-Mullerian Hormone/metabolism , Cabergoline , Cohort Studies , Female , Fertilization in Vitro , Follicular Fluid/metabolism , Hepatocyte Growth Factor/metabolism , Humans , Inhibins/metabolism , Insulin-Like Growth Factor I/metabolism , Ovarian Follicle/metabolism , Ovarian Hyperstimulation Syndrome/etiology , Ovarian Hyperstimulation Syndrome/metabolism , Polycystic Ovary Syndrome/metabolism , Polycystic Ovary Syndrome/therapy , Risk Factors , Young Adult
17.
J Matern Fetal Neonatal Med ; 26(6): 576-80, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23130645

ABSTRACT

OBJECTIVE: To compare cord blood oxidative stress markers (OSM) between intrauterine small fetuses with high umbilical artery (UA) Doppler indices and normal indices. METHODS: Forty women who had oligohydramnios and intrauterine growth-restricted fetuses with abnormal (n = 20, group I) or normal Doppler indices (n = 20, group II) were included. All patients underwent fetal Doppler ultrasound studies. Cord blood was collected at birth and six OSMs (ischemia-modified albumin (IMA), hepatocyte growth factor (HGF), malondialdehyde (MDA)) levels, total oxidant status (TOS), total antioxidant status (TAS), and oxidative stress index (OSI) were studied. RESULTS: The mean cord blood IMA, MDA, TOS, and OSI values for group I were significantly increased when compared to the group II (p < 0.001 for IMA, MDA, TOS, and OSI). However the mean cord blood HGF and TAS values were statistically significantly decreased in group I, compared with group II (p < 0.001 for HGF, and TAS). A significant positive (for IMA, MDA,TOS levels, and OSI ratio) and negative (for HGF and TAS levels) correlations between UA pulsatility index (PI) and cord blood OSM were found. CONCLUSION: The correlation between cord blood OSM and Doppler blood flow changes shown in this study may contribute to understanding the underlying oxidative stress-related mechanisms.


Subject(s)
Biomarkers/blood , Fetal Growth Retardation/blood , Fetal Growth Retardation/diagnostic imaging , Oxidative Stress , Umbilical Arteries/diagnostic imaging , Adult , Female , Fetal Blood/metabolism , Fetal Growth Retardation/physiopathology , Humans , Pregnancy , Pulsatile Flow , Ultrasonography, Doppler, Pulsed , Ultrasonography, Prenatal , Umbilical Arteries/physiopathology , Young Adult
18.
Fertil Steril ; 95(1): 290.e5-8, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20646692

ABSTRACT

OBJECTIVE: To report a rare case of male infertility associated with oligoasthenoteratozoospermia and complementary isochromosome 46 XY, i(9)(p10),i(9)(q10). DESIGN: Case report. SETTING: Reference hospital. PATIENT(S): Infertile oligoastenozoospermic man with complementary isochromosome 46,XY, i(9)(p10),i(9)(q10). INTERVENTION(S): Peripheral blood lymphocytes obtained for karyotyping, and florescence in situ hybridization (FISH) analysis for gonadal mosaicism in ejaculated spermatozoa. MAIN OUTCOME MEASURE(S): Physical examination, semen analysis, GBG banding, and FISH procedure. RESULT(S): The semen analysis revealed oligoasthenoteratozoospermia. The lymphocytic karyotype detected a complementary isochromosome 46,XY, i(9)(p10),i(9)(q10), and the FISH procedure showed abnormal sperm. CONCLUSION(S): This the first report of oligoasthenoteratozoospermia associated with complementary isochromosome 46,XY, i(9)(p10),i(9)(q10).


Subject(s)
Asthenozoospermia/genetics , Chromosomes, Human, Pair 9 , Infertility, Male/genetics , Isochromosomes , Oligospermia/genetics , Adult , Chromosome Banding , Female , Humans , Male , Translocation, Genetic/genetics
19.
Acta Obstet Gynecol Scand ; 89(7): 889-95, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20583934

ABSTRACT

OBJECTIVE: To compare the success rates of single and multiple dose methotrexate protocols for the treatment of unruptured tubal ectopic pregnancy. DESIGN: Prospective randomized controlled trial. SETTING: Maternity and teaching hospital in Turkey. POPULATION: One hundred twenty women treated with methotrexate therapy for unruptured tubal ectopic pregnancy. METHODS: Sixty-two women received a single dose and 58 received a multiple dose methotrexate regimen. MAIN OUTCOME MEASURES: Success rate of methotrexate therapy (women successfully treated with one injection and women who completed four doses). RESULTS: In the single dose group, treatment was considered successful in 50 women (80.6%), whereas in the multiple dose group, 52 women (89.7%) responded to treatment (p = 0.21; OR 0.90, 95%CI 0.77-1.05). The average number of days required for human chorionic gonadotropin (hCG) levels to fall below 5 mU/mL was longer in the single dose (22.3 +/- 7.6) compared with the multiple dose group (18.3 +/- 10.7) (p = 0.03). In the single dose group fewer or 17 women (24.7%) experienced side-effects compared to 28 (48.3%) of those who had multiple doses (p = 0.02, OR 0.57, 95%CI 0.35-0.92). CONCLUSION: A multiple dose methotrexate regimen for the treatment of unruptured tubal ectopic pregnancy is not more effective than a single dose one. In addition, multiple doses may cause more side-effects, but the time for hCG levels to fall below 5 mU/mL is shorter.


Subject(s)
Abortifacient Agents, Nonsteroidal/administration & dosage , Methotrexate/administration & dosage , Pregnancy Outcome , Pregnancy, Tubal/drug therapy , Abortifacient Agents, Nonsteroidal/adverse effects , Adolescent , Adult , Chi-Square Distribution , Dose-Response Relationship, Drug , Drug Administration Schedule , Female , Gestational Age , Humans , Methotrexate/adverse effects , Middle Aged , Odds Ratio , Parity , Pregnancy , Pregnancy, Tubal/diagnostic imaging , Prospective Studies , Risk Assessment , Statistics, Nonparametric , Treatment Outcome , Ultrasonography , Young Adult
20.
J Obstet Gynaecol Res ; 36(2): 418-23, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20492399

ABSTRACT

Brucellosis is one of the most common zoonotic diseases that can be encountered during pregnancy. We present two pregnant women with brucellosis. One of them delivered normally and the other patient had an abortion. We reviewed the literature regarding the clinical course of brucellosis in pregnant women. Brucellosis during pregnancy can be associated with abortion, congenital and neonatal infections and infection of the delivery team. Therefore treatment with a combination of rifampicin and trimethoprim-sulfamethoxazole should be started as soon as it is diagnosed to prevent possible complications.


Subject(s)
Abortion, Spontaneous/etiology , Brucellosis/complications , Pregnancy Complications, Infectious/drug therapy , Adult , Brucellosis/drug therapy , Female , Humans , Pregnancy , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...